Literature DB >> 12559980

Nitroxyl-mediated disruption of thiol proteins: inhibition of the yeast transcription factor Ace1.

Natalie M Cook1, Masaru Shinyashiki, Matthew I Jackson, Felipe A Leal, Jon M Fukuto.   

Abstract

Among the biologically and pharmacologically relevant nitrogen oxides, nitroxyl (HNO) remains one of the most poorly studied and least understood. Several previous reports indicate that thiols may be a primary target for the biological actions of HNO. However, the intimate details of the chemical interaction of HNO with biological thiols remain unestablished. Due to their ability to grow under a variety of conditions, the yeast Saccharomyces cerevisiae represents a unique and useful model system for examining the chemistry of HNO with thiol proteins in a whole-cell preparation. Herein, we have examined the effect of HNO on the thiol-containing, metal-responsive, yeast transcription factor Ace1 under a variety of cellular conditions as a means of delineating the chemistry of HNO interactions with this representative thiol protein. Using a reporter gene system, we find that HNO efficiently inhibits copper-dependent Ace1 activity. Moreover, this inhibition appears to be a result of a direct interaction between Ace1 thiols and HNO and not a result of any chemistry associated with HNO-derived species. Thus, this report indicates that thiol proteins can be a primary target of HNO biochemistry and that HNO-mediated thiol modification is likely due to a direct reaction of HNO.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559980     DOI: 10.1016/s0003-9861(02)00656-2

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Nitroxyl gets to the heart of the matter.

Authors:  Martin Feelisch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

2.  Mechanisms of the interaction of nitroxyl with mitochondria.

Authors:  Sruti Shiva; Jack H Crawford; Anup Ramachandran; Erin K Ceaser; Tess Hillson; Paul S Brookes; Rakesh P Patel; Victor M Darley-Usmar
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

Review 3.  The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO.

Authors:  Nazareno Paolocci; Matthew I Jackson; Brenda E Lopez; Katrina Miranda; Carlo G Tocchetti; David A Wink; Adrian J Hobbs; Jon M Fukuto
Journal:  Pharmacol Ther       Date:  2006-11-29       Impact factor: 12.310

Review 4.  The emergence of nitroxyl (HNO) as a pharmacological agent.

Authors:  Christopher H Switzer; Wilmarie Flores-Santana; Daniele Mancardi; Sonia Donzelli; Debashree Basudhar; Lisa A Ridnour; Katrina M Miranda; Jon M Fukuto; Nazareno Paolocci; David A Wink
Journal:  Biochim Biophys Acta       Date:  2009-05-06

Review 5.  Playing with cardiac "redox switches": the "HNO way" to modulate cardiac function.

Authors:  Carlo G Tocchetti; Brian A Stanley; Christopher I Murray; Vidhya Sivakumaran; Sonia Donzelli; Daniele Mancardi; Pasquale Pagliaro; Wei Dong Gao; Jennifer van Eyk; David A Kass; David A Wink; Nazareno Paolocci
Journal:  Antioxid Redox Signal       Date:  2011-03-03       Impact factor: 8.401

Review 6.  The chemical biology of HNO signaling.

Authors:  Christopher L Bianco; John P Toscano; Michael D Bartberger; Jon M Fukuto
Journal:  Arch Biochem Biophys       Date:  2016-08-20       Impact factor: 4.013

7.  Reactions of HNO with heme proteins: new routes to HNO-heme complexes and insight into physiological effects.

Authors:  Murugaeson R Kumar; Jon M Fukuto; Katrina M Miranda; Patrick J Farmer
Journal:  Inorg Chem       Date:  2010-07-19       Impact factor: 5.165

8.  Kinetic feasibility of nitroxyl reduction by physiological reductants and biological implications.

Authors:  Matthew I Jackson; Tae H Han; Laura Serbulea; Andrew Dutton; Eleonora Ford; Katrina M Miranda; K N Houk; David A Wink; Jon M Fukuto
Journal:  Free Radic Biol Med       Date:  2009-07-02       Impact factor: 7.376

9.  Generation of nitroxyl by heme protein-mediated peroxidation of hydroxylamine but not N-hydroxy-L-arginine.

Authors:  Sonia Donzelli; Michael Graham Espey; Wilmarie Flores-Santana; Christopher H Switzer; Grace C Yeh; Jinming Huang; Dennis J Stuehr; S Bruce King; Katrina M Miranda; David A Wink
Journal:  Free Radic Biol Med       Date:  2008-05-03       Impact factor: 7.376

Review 10.  Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties.

Authors:  Mai E Shoman; Omar M Aly
Journal:  Oxid Med Cell Longev       Date:  2015-12-07       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.